Jan 29, 2025 09:22AM
Aug 10, 2023 04:30PM
May 23, 2023 01:20PM
Apr 27, 2023 08:00AM
Mar 3, 2023 08:00AM
Feb 10, 2023 07:00AM
Jan 19, 2023 09:37AM Advaxis and Ayala Pharmaceuticals Complete Merger
Oct 19, 2022 06:31AM
Oct 19, 2022 06:30AM
Oct 19, 2022 06:30AM
Nov 11, 2021 08:00AM
Jul 6, 2021 09:30AM
Apr 2, 2021 07:33AM
Jan 25, 2021 07:00AM Advaxis Reports Fiscal Year 2020 Financial Results and Provides a Business Update
Nov 23, 2020 05:23PM
Sep 24, 2020 08:02AM
Sep 24, 2020 08:00AM
Mar 13, 2020 09:00AM
Feb 11, 2020 09:22AM
Jan 7, 2020 08:02AM
Jan 7, 2020 08:00AM Advaxis Announces FDA Clearance of IND for ADXS-504 for Treatment of Prostate Cancer
Dec 20, 2019 08:00AM
Dec 3, 2019 08:02AM
Dec 3, 2019 08:00AM
Oct 24, 2019 09:00AM
Oct 10, 2019 08:09AM
Oct 10, 2019 08:00AM
Oct 7, 2019 08:02AM Advaxis (ADXS) Reports Updated Prolonged Survival Data in Phase 1/2 ADXS-PSA Trial
Oct 7, 2019 08:00AM
Jul 15, 2019 08:02AM
Jul 15, 2019 08:00AM
Jun 27, 2019 06:53AM
Jun 27, 2019 06:50AM
Jun 10, 2019 04:05PM
Jun 4, 2019 08:00AM Advaxis to Host Business Update Conference Call on June 11, 2019
May 15, 2019 08:03AM
May 15, 2019 08:00AM
May 14, 2019 09:00AM
May 13, 2019 03:00PM
May 7, 2019 09:00AM
Apr 1, 2019 08:03AM
Apr 1, 2019 08:00AM ADXS-PSA in Combination with KEYTRUDA® Prolonged Survival in Metastatic Castration-Resistant Prostate Cancer
Mar 29, 2019 03:01PM
Mar 29, 2019 03:00PM
Mar 28, 2019 01:03PM
Mar 28, 2019 01:00PM
Mar 25, 2019 08:04AM
Mar 25, 2019 08:00AM
Mar 12, 2019 08:00AM Advaxis Reports First Quarter Fiscal 2019 Financial Results and Provides Clinical Pipeline Update
Feb 14, 2019 08:31AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All